Associate Professor, Health Policy and Management, Mailman School of Public Health
600 West 168th Street
New York NY 10032
Bhaven Sampat, Ph.D., is an associate professor in the Department of Health Policy and Management at Columbia's Mailman School of Public Health. He also holds a courtesy affiliation with Columbia's School of International and Public Affairs (SIPA), teaches in SIPA's MPA and MIA programs, and in the Sustainable Development PhD program at the Earth Institute.
An economist by training, Sampat is centrally interested in issues at the intersection of health policy and innovation policy. His current work examines the causes and consequences of generic firms’ challenges to pharmaceutical patents in the U.S., the impact of pharmaceutical patent laws on innovation and access to medicines in the developing countries, the political economy of the National Institutes of Health, and the returns to publicly funded medical research. Dr. Sampat has also written extensively on the effects of university patenting and the Bayh-Dole Act on academic medicine, and on patent quality issues in the U.S., and continues to be actively involved in policy debates related to these issues.
He has published broadly in economics, law, business, health policy, medical and life science journals, including past or forthcoming articles in the Review of Economics and Statistics, Journal of Law and Economics, Economics Letters, International Journal of Industrial Organization, the Journal of Economic Behavior and Organization, Management Science, Emory Law Journal, North Carolina Law Review, Health Affairs, New England Journal of Medicine, American Journal of Public Health, the Journal of Health Politics, Policy, and Law, Nature Biotechnology, PLoS Biology, and Nature.
Sampat co-created the first free, searchable patent database in India. He was the principal organizer of the TRIPS@10 conference at Columbia (earth.columbia.edu/tripsat10) which examined the effects of new global patent laws on developing countries.
Dr. Sampat received his B.A., M.A., M.Phil., and Ph.D. in economics from Columbia. He was previously an Assistant Professor at the School of Public Policy at Georgia Tech, where he won the “Faculty Member of the Year” teaching award in 2001-2 and in 2002-3. From 2003 to 2005 he was a Robert Wood Johnson Foundation Scholar in Health Policy Research at the University of Michigan. Together with C. Scott Hemphill, he is currently a recipient of a grant from the Robert Wood Johnson Foundation’s Public Health Law Research Program to study generic challenges to pharmaceutical patents. He previously received a Robert Wood Johnson Foundation "Investigator Award" to examine how the NIH allocates its funds across disease areas. He has also been funded by the Ford Foundation, the Merck Foundation, and the Commonwealth Fund.